A selective enzyme instead of thrombin
Clot formation needs fibrinogen to become fibrin; physiologically, thrombin drives that conversion. But thrombin is also a strong platelet activator, and a large share of the growth factors is released quickly into the surroundings and lost. Batroxobin converts fibrinogen through a different, more selective mechanism; platelets stay inactive, growth factors are preserved, and tissue healing gets a balanced regenerative effect.
- Selective enzymatic mechanism
- No platelet activation
- Controlled release











